Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

YEAR 2 - Principles of Pathology > 42. Degenerative Disease Due To Amyloid (HT) > Flashcards

42. Degenerative Disease Due To Amyloid (HT) Flashcards

1
Q

What are some examples of chronic degenerative disorders?

A
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Huntington’s Disease
  • Type II diabetes
  • Senile heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chronic degenerative diseases are diseases of…

A

Ageing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the population impact and demographics of chronic degenerative diseases.

A
  • They are under-recognised in terms of their effect on long-term morbidity and mortality
  • The number of cases each year is increasing due to:
    • Better diagnosis
    • Ageing population
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are amyloid diseases?

A
  • They are diseases characterised by fibrous deposition of amyloid within cells, leading to their dysfunction and provoking degenerative reactions
  • They include diseases such as Alzheimer’s disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Summarise the formation of amyloid.

[EXTRA but useful]

A
  • Normal host proteins are misfolded -> This often involves a change from alpha helix-rich to beta sheet-rich proteins
  • These misfolded protein accumulate first in oligomers, then protofibrils and finally 7-10nm fibrils
  • They are resistance to proteases, so they build up
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some possible causes of amyloid diseases?

A
  • Infectious -> Pathogen’s abnormal protein causes a change in the host cell protein (e.g. vCJD)
  • Genetic -> Inherited propensity for a protein to misfold (e.g. FFI)
  • Chronic disease -> Leads to excess production of serum proteins, which can be misfolded
  • Ageing -> Failure of normal clearance mechanisms)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What protein do amyloid disorders involve?

A

They all affect a specific protein (not the same one).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the pathological consequences of amyloid diseases?

[IMPORTANT]

A
  • The specific protein affected determines which tissues will be affected
  • The damage directly or indirectly (via inflammation) leads to cell loss and loss of function
  • Chronic inflammation is increasingly implicated as a source of damage in these diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do amyloid diseases differ in?

[IMPORTANT]

A

Amyloid diseases differ in:

  • Identity of the protein involved
  • Site of deposition
  • Pathological consequences
  • Causative or risk factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is amyloid?

A
  • Fibrous deposits of insoluble patient protein or protein fragment (usually extracellular)
  • Amyloid is usually protease-resistant, fibrillar and dominated by beta-sheet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How can amyloid be stained for?

[EXTRA]

A

Deposits stain with Congo Red and show “apple green” birefringence under polarizing light.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the peripheral amyloid disorders you need to know about?

A
  • Alzheimer’s disease (senile dementia)
  • Parkinson’s disease
  • Secondary (peripheral) amyloidoses in chronic inflammatory diseases
  • Type II diabetes
  • vCJD

EXTRA:

  • Senile systemic amyloidosis
  • Sporadic CJD
  • Dialysis-associated amyloidosis
  • Familial CJD
  • Iatrogenic CJD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

For senile systemic amyloid disease, state:

  • Abnormal protein
  • Cause
  • Pathology

[EXTRA]

A
  • Abnormal protein -> Transthyretin
  • Cause -> Ageing
  • Pathology -> Congestive heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

For dialysis-associated amyloid disease, state:

  • Abnormal protein
  • Cause
  • Pathology

[EXTRA]

A
  • Abnormal protein -> β2-microglobulin
  • Cause -> Dialysis
  • Pathology -> Carpal tunnel syndrome, Deposits in bone and tendons, Joint effusion and pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

For familial visceral amyloid disease, state:

  • Abnormal protein
  • Cause
  • Pathology

[EXTRA]

A
  • Abnormal protein -> Fibrinogen, α-chain, apoL1, Lysozyme
  • Cause -> Genetic
  • Pathology -> Renal disease, Organomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

For secondary amyloid disease, state:

  • Abnormal protein
  • Cause
  • Pathology
A
  • Abnormal protein -> Serum amyloid A precursor protein [EXTRA]
  • Cause -> Chronic inflammation
  • Pathology -> Heart and kidney
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Where globally are secondary (peripheral) amyloidoses in chronic inflammatory diseases most commonly seen?

[IMPORTANT]

A

In developing countries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

For type II diabetes as an amyloid disease, state:

  • Abnormal protein
  • Cause
  • Pathology
A
  • Abnormal protein -> 37-mer Islet amyloid precursor polypeptide
  • Cause -> Chronic inflammation
  • Pathology -> Pancreatic islet dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which system is particularly prone to amyloid diseases?

A

CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are some amyloid diseases of the CNS?

A
  • Alzheimer’s disease
  • Parkinson’s disease
  • vCJD

EXTRA:

  • Amyloidoma
  • Creutzveldt-Jakob disease
  • Fatal familial insomnia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

For Alzheimer’s disease, state:

  • Abnormal protein
  • Part of the CNS affected
A
  • Abnormal protein -> Amyloid β A4 precursor protein (APP) or Presenilin 1 or 2 [EXTRA]
  • Part affected -> Cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

For Parkinson’s disease, state:

  • Abnormal protein
  • Part of the CNS affected
A
  • Abnormal protein -> α-Synuclein
  • Part affected -> Basal ganglia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

For amyloidoma, state:

  • Abnormal protein

[EXTRA]

A
  • Abnormal protein -> IgG light chain
24
Q

For Creutzveldt-Jakob disease, state:

  • Abnormal protein
  • Cause
A
  • Abnormal protein -> PrP (prion protein)
  • Cause -> Spontaneous
25
Q

For vCJD, state:

  • Abnormal protein
  • Cause
A
  • Abnormal protein -> PrP (prion protein)
  • Cause -> Infectious
26
Q

For fatal familial insomnia, state:

  • Abnormal protein
  • Cause

[EXTRA]

A
  • Abnormal protein -> PrP (prion protein)
  • Cause -> Genetic
27
Q

What is CJD?

A

Creutzveldt-Jakob disease

28
Q

What are some diseases caused by prions?

A
  • Creutzveldt-Jakob disease
  • vCJD
  • Fatal familial insomnia [EXTRA]
29
Q

What are prions and how do they relate to amyloids?

A
  • Prions are misfolded proteins with the ability to transmit their misfolded shape onto normal variants of the same protein.
  • They characterize several fatal and transmissible neurodegenerative diseases.
  • Prions are a subclass of amyloids in which protein aggregation becomes self-perpetuating and infectious.
30
Q

What are prion diseases and what are they caused by?

A
  • A family of chronic neurodegenerative diseases characterised by extensive neuronal loss without replacement by glial cells, leaving large vacuolated areas clearly seen in histological sections
  • They are often fatal
  • Causes: Sporadic, genetic predisposition or infectious
31
Q

What are the features of prion diseases?

A
  • Progressive
  • Irreversible
  • Fatal
  • Vacuolating neurodegeneration
  • Often amyloid plaques
  • Often diffuse and/or focal accumulations of proteaseresistant PrP
  • Infectivity associated with abnormal PrP, no DNA
32
Q

What enables the infectivity of prion diseases?

A

The abnormal prion protein (PrP) itself conveys infectivity, not any DNA.

33
Q

What are the symptoms of Creutzveldt-Jakob disease?

A
  • Rapidly developing delirium or dementia (over the course of a few weeks or months)
  • Blurred vision (sometimes)
  • Changes in gait
  • Hallucinations
  • Lack of coordination (for example, stumbling and falling)
  • Muscle twitching
  • Muscle stiffness
  • Myoclonic jerks or seizures
  • Nervous, jumpy feelings
  • Personality changes
  • Profound confusion, disorientation
  • Sleepiness
  • Speech impairment
34
Q

Give a working definition of prions.

A
  • A small proteinaceous infectious particle which resists inactivation by procedures that modify nucleic acids
  • In other words, processes that decrease the infectivity of other things dependent on nucleic acids (e.g. bacteria, genes), such as UV radiation, do not affect the prions
35
Q

Can prions be denatured?

A
  • Yes, but they can renature without any loss of infectivity.
  • This can explain why traditional methods of cleaning equipment after surgery may not prevent the spread of prion diseases.
36
Q

Do prion diseases require a constant production of the endogenous PrP protein? Give some experimental evidence for this.

A
  • Yes, because prion diseases involve deposition of misfolded PrP
  • There needs to be continued production, or else the disease progression stops
  • (Mallucci, 2007):
    • Mice burrowing is a protective mechanism in response to danger
    • In mice with prion disease, this function is progressively lost
    • However, if the endogenous expression of the PrP protein is stopped, then the disease does not progress
37
Q

Describe the diagnosis of prion diseases.

[EXTRA]

A
  • Definitive diagnosis is at post-mortem by histo- and immuno-pathology
  • Diagnosis in living patients is more difficult, often requiring brain biopsy or use of low specificity tests on CSF
  • Biochemical assays based on antibody binding or protease resistance are time-consuming and of low sensitivity and/or specificity
  • A different diagnostic tool depends on patient samples seeding in vitro amyloid growth detected by a fluorescent dye that binds fibrils
  • The assay requires constant shaking of the assay plate, leading to the recognition that the agitated airwater interface is critical for catalysis of assembly
38
Q

How can genetics lead to amyloid diseases?

A
  • Then can affect protein folding, stability and processing.
  • This can lead to misfolded proteins, which lead to amyloid deposition
39
Q

What is the demographic for Alzheimer’s disease?

A

It is typically a disease of the elderly, but there is also a rare early onset familial form.

40
Q

What parts of the brain does Alzheimer’s affect?

A
  • Progressive irreversible damage to sub-cortical and then cortical regions
  • This leads to shrinkage of brain tissue
41
Q

What are the symptoms of Alzheimer’s disease?

A
  • First, degeneration of hippocampus leads to short-term memory loss
  • Then there is progressive loss of judgement, control of mood, face recognition, communication, continence
  • 4-12 years from diagnosis to death
42
Q

Do we have good treatments for Alzheimer’s disease?

A

There are drugs to treat the symptoms, but no curative treatments.

43
Q

How can Alzheimer’s be diagnosed?

A
44
Q

Describe the pathology of Alzheimer’s.

A

Alzheimer’s is an progressive amyloid disease:

  • Extracellular amyloid plaques form between neurons and are composed of fibrils of proteolytic fragments of APP -> They are of unknown pathological significance
  • Intracellular neurofibrillary tangles also form and are composed of fibrils of hyperphosphorylated Tau protein (a microtubule-associated protein) in neurons
  • These two effects lead to collapse of neuronal structure & connexions
  • Local inflammatory responses by glial cells also contribute to the pathology
45
Q

How and why does amyloid form?

A
  • Amyloid fibrils contain extensive stacked beta sheets, like silk
  • The parent protein that the amyloid forms from is often natively alpha helix rich
  • The alpha to beta conversion is helped by:
    • Proteolysis
    • Small side chains
    • Unstable native fold
    • Denaturing conditions
    • Presence of “seed”
    • Stabilizing co-factors
46
Q

Which protein is involved in the pathology of Alzheimer’s disease?

A
  • APP (amyloid precursor protein) is an integral membrane protein
  • When it is cleaved in the right place, it forms amyloid beta (Aβ), which forms fibrils that are the main component of amyloid plaques in Alzheimer’s disease
47
Q

Describe how amyloid is involved in the pathogenesis of Alzheimer’s disease.

[EXTRA?]

A
  • Familial AD and sporadic AD, as well as altered APP, can lead to changes in calcium homeostasis in the cell
  • This leads to hyperphosphorylation of TAU (the intracellular protein that aggregates in AD)
  • All of these previous effects lead to downstream effects, such as:
    • Oxidative damage
    • Altered synaptic plasticity
    • Excitotoxicity
    • Apoptosis/necrosis
  • It is also suggested that when the normal pathway for the clearance of amyloidogenic monomers is saturated, then an overflow pathway is opened, which leads to the formation of fibrils and dysfunction
48
Q

What size of amyloid is responsible for Alzheimer’s disease? What is some experimental evidence for this?

A

(Demuro, 2005):

  • Amyloid oligomers have the greatest effect
  • This can be tested by adding in sequence monomer, oligomers and fibrils, then seeing what effect this has on intracellular calcium levels (which is part of the pathology of Alzheimer’s)
  • Oligomers are the only ones to produce an increase in calcium
49
Q

Describe which part of the cell amyloid plaques associate with in Alzheimer’s disease.

A

Cell membrane -> It exhibits some spontaneous channel activity.

50
Q

How is chronic inflammation involved in the pathology of Alzheimer’s disease?

A
  • Scavenger receptor enable uptake of amyloid by microglial cells
  • These then release cytokines and proteases
  • When the microglial cells’ lysosomes become full, they regurgitate the toxic processed amyloid fragments
  • Released partially digested fibril components form toxic extracellular species that bind to and damage the plasma membrane of neighbouring cells leading to bystander killing
51
Q

How can the degree of chronic inflammation in Alzheimer’s disease be assessed?

A
  • Microglial cells produce insulin-degrading enzyme (IDE), which degrades amyloid monomers in the brain.
  • The levels of this tell you about the level of inflammation.
52
Q

Give some experimental evidence for the importance of chronic inflammation in Alzheimer’s disease.

[EXTRA]

A

(Vom Berg, 2012):

  • Wild-type mice will quickly find the correct platform in a Barnes maze test based on memory
  • If the mouse is made to express an amyloidigenic protein, then the mouse will be not be able to remember where the platform is
  • However, if a blocker for IL-12 and IL-23 is used, then the mouse acts as normal, showing the importance of chronic inflammation in Alzheimer’s disease
53
Q

What are some treatment approaches for amyloid diseases?

[EXTRA]

A

General approaches:

  • Immunization with precursor to aid clearance (autoimmunity)
  • Inhibition of endoproteases that release amyloidogenic fragments
  • Metal ion chelation
  • Inhibitors of fibril formation (NB Perhaps inhibition of oligomer formation)

Specific approaches for AD:

  • Anticholinesterases (Three licensed for AD)
  • Memantine (NMDA receptor antagonist)
  • Gamma secretase inhibitors (so far all have failed at Phase III trials)
  • Beta secretase inhibitors (problems with oral availability, BBB penetration)
  • Passive immunisation against amyloid proteins (increase clearance)
  • Anti-inflammatory drugs (Glial cytoprotection)
  • Anti-tau approaches (experimental)
54
Q

What neurons are most severely affected in Alzheimer’s disease?

A

Cholinergic

55
Q

What is another name for Alzheimer’s disease?

A

Senile dementia

56
Q
A

YEAR 2 - Principles of Pathology (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions